Leverage Data and Analytics to Support Life Science’s
Messaging to Healthcare Providers (HCP)
Data and analytics provides transparency for Life Science’s organizations to drive HCP engagement and collaboration as well as support of intervention planning and adherence for patients with pre-existing medical conditions*.
ANALYTICS DRIVEN INSIGHTS
US View: Prevalence of Patients with Diabetes and Active COVID 19 Cases
COUNTY LEVEL ANALYSIS PROVIDES INSIGHTS INTO EMERGING GEOGRAPHICAL HOT SPOTS FOR VULNERABLE PATIENTS AT GREATER RISK TO SUFFER IMPACTS FROM COVID-19
US View: Prevalence of Patients with Heart Disease and Active COVID-19 Cases
EVALUATION OF THE AT-RISK POPULATION CAN HELP DECISION MAKERS UNDERSTAND WHERE TO FOCUS HCP COMMUNICATION, EDUCATION AND COPAY ASSISTANCE FOR PATIENTS WITH PRE-EXISTING CONDITIONS
US View: Prevalence of Patients with Lung Disease and Active COVID-19 Cases
US View: Prevalence of Patients with Immunosuppresant and Active COVID-19 Cases
US View: Prevalence of Patients with Kidney Disease and Active COVID-19 Cases
EXL is here for you – Contact us to learn more or to discuss your unique needs.
*Analysis is based on EXL Healthcare’s Commercial Internal Benchmark representative of the US population.
At Risk individuals in the analysis include one of the following pre-existing conditions: Heart Disease, Lung Disease or Diabetes. According to the CDC (https://www.cdc.gov/coronavirus/2019-ncov/specific-groups/high-risk-complications.html) people with pre-existing medical conditions such as Heart Disease, Diabetes and Lung Disease face a higher risk for severe illness related to COVID-19
Active COVID-19 case reporting data: https://coronavirus.1point3acres.com/
To learn more about EXL Healthcare, visit www.exlservice.com/healthcare